KATHLEEN ROSE: Open Payments
NPI 1871926204 · CANANDAIGUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,301 in 207 payments from 14 companies in 2025. Trend: 2023 $3,452 · 2024 $3,292 · 2025 $3,301
Food & beverage: $3,301
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 47 | $715 |
| ABBVIE INC. | 25 | $413 |
| Lundbeck LLC | 18 | $358 |
| Vanda Pharmaceuticals Inc. | 14 | $291 |
| Axsome Therapeutics, Inc. | 22 | $282 |
| Teva Pharmaceuticals USA, Inc. | 20 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $208 |
| Otsuka America Pharmaceutical, Inc. | 10 | $192 |
| Neurocrine BioSciences, Inc. | 12 | $176 |
| Alkermes, Inc. | 9 | $165 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Auvelity, TRINTELLIX, AUSTEDO XR, INGREZZA, FANAPT.
Industry payments across NY — which companies pay providers there.
